Biocon Group on Tuesday reported a 20% year-on-year increase in operating revenues in the second quarter of FY26 to Rs 4,296 crore, driven by robust growth in biosimilars, improved momentum in generics and steady contribution from the CRDMO segment.EBITDA grew 29% to Rs 928 crore, while net profit for the period stood at Rs 85 […]
